Screening for Pancreatic Cancer Research
Health News about the Screening for Pancreatic Cancer by David V. Gold, PhD, of the Garden State Cancer Center in Belleville, NJ.David V. Gold, PhD forecast tests used to screen people at high risk of pancreatic cancer such as long-term diabetes, chronic pancreatitis, the people with a history of tobacco or alcohol use, and people with a family history or genetic factors that place them at increased risk.David V. Gold, PhD that if a doctor suspects pancreatic cancer, tests can be used to distinguish between different types of cancer and healthy tissue with the test will be available in two to three years.In a separate study of 21 men with advanced pancreatic cancer, the researchers also tested whether the antibodies can be used as a treatment to bring targeted agents for cancer.Antibodies attached to radioactive isotopes, and injected into the body. The idea is that after the houses in antibodies on tumor cells, radiation is released, killing the tumor cells while saving healthy tissue.In the study, tumors shrank in 23% of patients and stopped growing in an additional 45%, said Gold.Robert P. Sticca, MD, of North Dakota School of Medicine and Health Sciences, which managed the news briefing, tells WebMD that he was very enthusiastic about the possibilities.
David V. Gold, PhD, of the Garden State Cancer Center in Belleville, NJ stated that if we have a blood test that can detect cancer early, we can better manage our patients and we’d have a little death. The added benefits of using it as a treatment option is also very interesting.
